MECHANISMS OF ANTI-PROLIFERATIVE EFFECT PRODUCED BY MESENCHYMAL STEM CELLS IN PATIENTS WITH MULTIPLE SCLEROSIS
Abstract. We investigated the ability of autologous/allogeneic mesenchymal stem cells (MSC) from early passages, derived from bone marrow of patients with multiple sclerosis, to inhibit mitogen/myelin-induced proliferation of memory T cells. It was shown that MSC immunosuppressive potenti...
Guardado en:
Autores principales: | M. M. Zafranskaya, D. B. Nizhegorodova, M. Yu. Yurkevich, S. S. Bagatka, H. I. Ivanchyk, Yana M. Motuzova, A. S. Fedulov |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7f19bed10f4d40aa8b8a8c89bdb016b4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Function of the Kynurenine Pathway in the Placenta: A Novel Pharmacotherapeutic Target?
por: Michelle Broekhuizen, et al.
Publicado: (2021) -
Hepatocellular Carcinoma Cells Are Protected From Immunolysis by Mesenchymal Stromal Cells Through Indoleamine 2,3 Dioxygenase
por: Raghavan Chinnadurai, et al.
Publicado: (2021) -
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis
por: Rivera,Francisco J, et al.
Publicado: (2012) -
Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
por: Corina Bello, et al.
Publicado: (2021) -
TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
por: V. A. Kozlov, et al.
Publicado: (2017)